Seaport Therapeutics
Signal active
Organization
Contact Information
Overview
Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
About
Industries
Biotechnology, Pharmaceutical
Founded
Invalid date
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Seaport Therapeutics headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical sector. The company focuses on Biotechnology and has secured $800.0M in funding across 8 round(s). With a team of 11-50 employees, Seaport Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Seaport Therapeutics, raised $100.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
4
Lead Investors
0
Total Funding Amount
$100.0M
Details
1
Seaport Therapeutics has raised a total of $100.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Early Stage Venture | 100.0M |
Investors
Seaport Therapeutics is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Eric Elenko | - | FUNDING ROUND - Eric Elenko | 100.0M |
| Bharatt Chowrira | - | FUNDING ROUND - Bharatt Chowrira | 100.0M |
| Seaport Therapeutics | - | FUNDING ROUND - Seaport Therapeutics | 100.0M |
| PureTech Health | - | FUNDING ROUND - PureTech Health | 100.0M |
Recent Activity
There is no recent news or activity for this profile.